Skip to main content

Table 1 Baseline demographics and clinical and characteristics of patients with different MIC values

From: Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

 

MIC distribution data

Total

P -value

Characteristics

≤0.016

0.031

0.062–0.125

0.25

Gender (male/female)

11/12

14/17

6/5

2/1

33/35

0.9185

Age, mean ± SD (years)

45 ± 11.43

41 ± 10.84

42±

10.80

38 ± 12.70

42 ± 11.06

0.5475

Cigarette smoking (yes/no)

6/17

8/23

2/9

2/1

18/50

0.4952

Alcohol drinking (yes/no)

9/14

13/18

6/5

0/3

28/40

0.4737

Endoscopic findings (PUD/NUD)

4/19

8/23

5/6

0/3

17/51

0.2890

Eradication rate

100% (23/23)

93.55% (29/31)

90.91% (10/11)

100% (3/3)

95.59% (65/68)

0.4736

BQT

100% (17/17)

91.67% (22/24)

87.5% (7/8)

100% (3/3)

94.23% (49/52)

0.4923

Others

100% (6/6)

100% (7/7)

100% (3/3)

None

100% (16/16)

1.0000

  1. SD standard deviation, PUD peptic ulcer disease, NUD non-ulcer dyspepsia, BQT clarithromycin-containing bismuth quadruple therapy. Concentrations are in mg/L